1951 - 1975 of 9148 Results
Title
Year
-
OPENTitle: Disease-Modifying Antirheumatic Drugs and Risk of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 12Start Page: e1273End Page: e1281Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013303Best OA location URL: https://n.neurology.org/content/neurology/98/12/e1273.full.pdfCitation Count: 25
-
OPENTitle: Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT LocusJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 815695End Page: 815695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2022.815695Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2022.815695/pdfCitation Count: 17
-
OPENTitle: Sensor Measurements Can Characterize Fluctuations and Wearing Off in Parkinson’s Disease and Guide Therapy to Improve Motor, Non-motor and Quality of Life ScoresJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 852992End Page: 852992Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.852992Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.852992/pdfCitation Count: 14
-
OPENTitle: PhosPiR: an automated phosphoproteomic pipeline in RJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbab510Best OA location URL: https://academic.oup.com/bib/article-pdf/23/1/bbab510/43308900/bbab510.pdfCitation Count: 9
-
OPENTitle: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patientsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 88End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03032-5Best OA location URL: https://www.nature.com/articles/s42003-022-03032-5.pdfCitation Count: 33
-
OPENTitle: Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 628388End Page: 628388Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.628388Best OA location URL: https://doi.org/10.3389/fneur.2021.628388Citation Count: 28
-
OPENTitle: Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 750767End Page: 750767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.750767Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.750767/pdfCitation Count: 21
-
OPENTitle: Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalographyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 127Issue #: 1Start Page: 279End Page: 289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00316.2021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8782645Citation Count: 11
-
OPENTitle: Sex Differences in Brain and Cognition in de novo Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 791532End Page: 791532Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.791532Best OA location URL: https://doi.org/10.3389/fnagi.2021.791532Citation Count: 41
-
OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8770717Citation Count: 10
-
OPENTitle: Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD)Journal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 62End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12010062Best OA location URL: https://www.mdpi.com/2076-3425/12/1/62/pdf?version=1641260939Citation Count: 10
-
OPENTitle: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’sJournal Name: Journal of Patient-Reported OutcomesPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s41687-023-00577-9Best OA location URL: https://jpro.springeropen.com/counter/pdf/10.1186/s41687-023-00577-9Citation Count: 21
-
OPENTitle: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 3Start Page: 112231End Page: 112231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231Best OA location URL: https://doi.org/10.1016/j.celrep.2023.112231Citation Count: 63
-
OPENTitle: A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning ProcessesJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 2Start Page: 409End Page: 409Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22020409Best OA location URL: https://www.mdpi.com/1424-8220/22/2/409/pdf?version=1641453558Citation Count: 24
-
OPENTitle: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1138546End Page: 1138546Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1138546Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1138546/pdfCitation Count: 2
-
OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 11
-
OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 11
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 26
-
OPENTitle: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicityJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 2Start Page: e13130End Page: e13130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/bpa.13130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.13130Citation Count: 4
- B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression2023OPENTitle: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progressionJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 2Start Page: fcad060End Page: fcad060Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad060Best OA location URL: https://academic.oup.com/braincomms/article-pdf/5/2/fcad060/49650847/fcad060.pdfCitation Count: 42
-
OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 14
-
OPENTitle: Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 43End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00491-3Best OA location URL: https://www.nature.com/articles/s41531-023-00491-3.pdfCitation Count: 37
- EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease2023OPENTitle: EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 91Issue #: 4Start Page: 1557End Page: 1572Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-221152Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10039707/pdf/nihms-1865876.pdfCitation Count: 31
-
OPENTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 13
-
OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page: e859End Page: e871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 197